1 |
Freeman J, Wilcox MH. Antibiotics and Clostridium difficile. Microbes Infect. 1: 377-384 (1999)
DOI
ScienceOn
|
2 |
Homma N. Bifidobacteria as are resistance factor in human beings. Bifidobact. Microfl. 7: 35-43 (1988)
DOI
|
3 |
Colombel JF, Cortot A, Neut C, Romond C. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 330: 43 (1987)
|
4 |
Gorbach SL. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 330: 1519 (1987)
|
5 |
Van-Niel CW, Feudtner C, Garrison MN, Christakis DA. Lactobacillus therapy for acute infectious diarrhoea in children: A meta analysis. Pediatrics 109: 678-684 (2002)
DOI
ScienceOn
|
6 |
Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibioticassociated diarrhea in children. J. Pediatr. 135: 564-568 (1999)
DOI
ScienceOn
|
7 |
Tankanow RM, Ross MB, Ertel IJ, Dickinson DG, McCormick LS, Garfinkel JF. A double-blind, placebo-controlled study of the efficacy of lactinex in the prophylaxis of amoxicillin-induced diarrhea. Drug Intel. Clin. Phar. 24: 382-384 (1990)
|
8 |
Siitonen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wikberg R, Kirkkola AL. Effect of Lactobacillus GG yogurt in prevention of antibiotic associated diarrhoea. Ann. Med. 22: 57-59 (1990)
DOI
ScienceOn
|
9 |
Kim JT, Jung HY, Lee NK, Rhim SL, Paik HD. Isolation, identification, and probiotic properties of Lactobacillus reuteri HY701 from human feces. Food Sci. Biotechnol. 15: 677-682 (2006)
과학기술학회마을
|
10 |
Araki T, Shinozaki T, Irie Y, Miyazawa Y. Trial of oral administration of Bifidobacterium breve for the prevention of rotavirus infection. Kansenshogaku Zasshi 73: 305-310 (1999)
DOI
|
11 |
Takemoto T, Ogawa S, Nishimoto N, Hirayama H, Taniguchi S. Studies on the constituents of Achyranthis radix. VII. The insectmoulting substances in Achyranthes and Cyathula genera 'supplement'. Yakuga. Zasshi 88: 1293-1297 (1968)
DOI
|
12 |
Saavadra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344: 1046-1069 (1994)
DOI
ScienceOn
|
13 |
Bae HS, Shin MS, Kim YJ, Baek YJ. Effects of the lactic acid bacteria administration on fecal microflora and putrefactive metabolites in health adults. J. Appl. Microbiol. Biotechnol. 24: 254-260 (1996)
|
14 |
Bergogne-Berezin E. Treatment and prevention of antibiotic associated diarrhea. Int. J. Antimicrob. Ag. 16: 521-526 (2000)
DOI
ScienceOn
|
15 |
Lee YJ, Yu WK, Heo TR. Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces. Int. J. Antimicrob. Ag. 21: 340-346 (2003)
DOI
ScienceOn
|
16 |
Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. New Engl. J. Med. 330: 257-262 (1994)
DOI
ScienceOn
|
17 |
Black FT, Andersen PL, Orskov J, Orskov F, Gaarslev K, Laulund S. Prophylactic efficacy of lactobacillus on traveller's diarrhoea. Travel Med. 7: 333-335 (1989)
|
18 |
Mark P. The effect of probiotics on Clostridium difficile diarrhea. Am. J. Gastroenterol. 95: 11-13 (2000)
DOI
|
19 |
Surawicz CM. Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Pract. Res. Cl. Ga. 17: 775-783 (2003)
DOI
|
20 |
Cartmill TD, Panigrahi H, Worsley MA, McCann DC, Nice CN, Keith E. Management of diarrhoea due to Clostridium difficile. J. Hosp. Infect. 27: 1-15 (1994)
DOI
ScienceOn
|
21 |
Lyerly DM, Saum KE, MacDonald DK, Wilkins TD. Effects of Clostridim difficile toxins given intragastrically to animals. Infect. Immun. 47: 349-352 (1985)
|
22 |
Orrhage K, Brismar B, Nord CE. Effects of supplements of Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin. Microb. Ecol. Health D. 7: 17-25 (1994)
DOI
ScienceOn
|
23 |
McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nocosomial acquisition of Clostridium difficile infection. New Eng. J. Med. 320: 204-210 (1989)
DOI
ScienceOn
|
24 |
Lee YM, Choi SI, Lee JW, Jung SM, Park SM, Heo TR. Isolation of hyaluronidase inhibitory component from the roots of Astragalus membranaceus Bunge (Astragali radix). Food Sci. Biotechnol. 14: 263-267 (2005)
|
25 |
Isolauri E, Juntunen M, Rautanen T. A human Lactobacillus strain (Lactobacillus casei sp. GG) promotes recovery from acute diarrhoea in children. Pediatrics 88: 90-97 (1991)
|
26 |
Isolauri E, Kaila M, Mykkanen H. Oral bacteriotherapy for viral gastroenteritis. Digest Dis. Sci. 39: 2595-2600 (1994)
DOI
ScienceOn
|
27 |
Son KH, Hwang JH, Lee SH, Park JH, Kang SJ, Chang SY, Lee KS. Isolation and quantitative determination of 20-hydroxyecdysone from Achyranthis radix. Korean J. Pharmacogn. 30: 335-339 (1999)
|
28 |
Sehgal M, Kyne L. Clostridium difficile Disease. Curr. Opin. Infect. Dis. 4: 201-210 (2002)
DOI
ScienceOn
|
29 |
Takemoto T, Ogawa S, Nishimoto N. Studies on the constituents of Achyranthis radix. II. Isolation of the insectmoulting hormones. Yakuga. Zasshi 87: 1469-1473 (1967)
DOI
|
30 |
Bartlett JG. Clostridium difficile: History of its role as an enteric pathogen and the current state of knowledge about the organism. Clin. Infect. Dis. 18: 5265-5275 (1994)
|
31 |
Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastr. Nutr. 20: 333-338 (1995)
DOI
ScienceOn
|
32 |
Gilliland SE. Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol. Rev. 87: 175-188 (1990)
DOI
|
33 |
Mitsuoka T. Bifidobacteria and their role in human health. J. Ind. Microbiol. 6: 263- 268 (1990)
DOI
|
34 |
Kim KT, Yeo EJ, Han YS, Nah SY, Paik HD. Antimicrobial, antiinflammatory, and anti-oxidative effects of water and ethanol extracted Brazilian propolis. Food Sci. Biotechnol. 14: 474-478 (2005)
|